A detailed history of Rothschild Investment LLC transactions in I Teos Therapeutics, Inc. stock. As of the latest transaction made, Rothschild Investment LLC holds 25 shares of ITOS stock, worth $213. This represents 0.0% of its overall portfolio holdings.

Number of Shares
25
Previous 10 150.0%
Holding current value
$213
Previous $148,000 72.3%
% of portfolio
0.0%
Previous 0.0%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 18, 2024

BUY
$10.09 - $17.97 $151 - $269
15 Added 150.0%
25 $255,000
Q2 2024

Jul 30, 2024

BUY
$10.33 - $18.09 $103 - $180
10 New
10 $148,000

Others Institutions Holding ITOS

About iTeos Therapeutics, Inc.


  • Ticker ITOS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 35,575,300
  • Market Cap $304M
  • Description
  • Iteos Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the discovery and development of immuno-oncology therapeutics for patients. The company's product pipeline includes inupadenant, a small molecule antagonist of the adenosine A2AR antagonists that is in Phase 2 clinical trials; and EOS-448, an antagonist of TIGIT or ...
More about ITOS
Track This Portfolio

Track Rothschild Investment LLC Portfolio

Follow Rothschild Investment LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Rothschild Investment LLC, based on Form 13F filings with the SEC.

News

Stay updated on Rothschild Investment LLC with notifications on news.